ALOX15 and Alzheimer disease: Pratico et al. reported an increase in the 15-LOX metabolic pathway in cortex of patients with AD as compared with control brains, and a direct correlation with an oxidative imbalance in the CNS, concluding a pro-inflammatory state (Praticò et al., 2004).